COPZ2

COPZ2 encodes the ζ2 subunit of the COPI coatomer complex that mediates intracellular vesicular trafficking and autophagy (PMID:21746916). It is functionally redundant with its paralog COPZ1: knockdown of COPZ2 alone does not cause Golgi collapse, autophagy block, or apoptosis, but simultaneous loss of both paralogs is required to impair normal cell growth (PMID:21746916). This redundancy becomes therapeutically relevant when COPZ2 is silenced—as occurs in tumor cells—rendering those cells uniquely dependent on COPZ1, such that re-expression of COPZ2 rescues them from COPZ1 knockdown-induced death (PMID:21746916), and transduction of COPZ2 into COPZ1-mutant human CD34+ cells restores defective granulopoiesis (PMID:39642330). COPZ2 expression is itself stress-regulated: hypoxia lowers COPZ2 and other COPI coatomer genes downstream of JNK activation, with a corresponding decline in ER-to-Golgi trafficking (PMID:27039902). The COPZ2 locus harbors miR-152 within an intron, and the two are co-silenced via DNA hypermethylation, but the tumor-suppressive activity maps to miR-152 rather than the COPZ2 protein (PMID:21746916).

1. 2011 High

   Established that COPZ2 is a COPI coatomer ζ subunit functionally redundant with COPZ1, resolving why its individual loss is phenotypically silent while combined paralog loss disrupts cell growth.

   Evidence siRNA knockdown with Golgi morphology, autophagy, apoptosis, and viability readouts in tumor and normal cells

   PMID:21746916

   Open questions at the time

   • No structural or biochemical demonstration of COPZ2 incorporation into the coatomer
   • Mechanism distinguishing COPZ1 vs COPZ2 contribution to specific cargo trafficking unknown
2. 2011 High

   Showed that tumor-specific COPZ2 silencing is the mechanistic basis for COPZ1 dependency, since COPZ2 re-expression protects tumor cells from COPZ1 knockdown.

   Evidence COPZ2 re-expression rescue with COPZ1 siRNA and viability/apoptosis assays across multiple cell lines

   PMID:21746916

   Open questions at the time

   • Does not define the trafficking cargoes whose loss kills COPZ2-silenced cells
   • In vivo therapeutic window of COPZ1 targeting not established here
3. 2011 Medium

   Distinguished the COPZ2 protein from its intronic miR-152, attributing the locus's tumor-suppressor activity to the microRNA rather than the protein.

   Evidence DNA methylation and expression profiling with functional separation of COPZ2 and miR-152 activities in tumor lines and clinical samples

   PMID:21746916

   Open questions at the time

   • Negative finding (no COPZ2 tumor-suppressor activity) not independently replicated
   • Regulatory coupling between COPZ2 transcription and miR-152 maturation not detailed
4. 2016 Medium

   Placed COPZ2 regulation downstream of JNK under hypoxic stress, linking coatomer gene expression to ER-to-Golgi trafficking capacity.

   Evidence JNK inhibition, siRNA, and ER-to-Golgi trafficking assays with qPCR in mouse islets and MIN6 cells

   PMID:27039902

   Open questions at the time

   • COPZ2 measured among several COPI genes, not isolated
   • Direct transcriptional mechanism of JNK-dependent COPZ2 repression unknown
5. 2025 Medium

   Extended COPZ2-COPZ1 redundancy to hematopoiesis by showing COPZ2 can compensate for COPZ1 mutation to restore granulopoiesis.

   Evidence Lentiviral COPZ2 transduction into COPZ1-mutant human CD34+ cells with granulocytic differentiation assays

   PMID:39642330

   Open questions at the time

   • Single study in primary cells without reciprocal validation
   • Molecular basis of COPZ1 requirement during granulopoiesis not defined

• It remains unknown how COPZ1 and COPZ2 differ at the level of cargo selectivity or coatomer assembly, and what dictates tissue- and tumor-specific silencing of COPZ2.
• No structural model of COPZ2-containing coatomer
• Substrate/cargo specificity distinguishing the paralogs undefined
• Regulators of COPZ2 epigenetic silencing beyond DNA hypermethylation unknown